TOKYO -- Japanese drugmaker Takeda Pharmaceuticals will invest $30 billion in the U.S. over the next five years, CEO Christophe Weber said Thursday, with the money going toward both manufacturing facilities and research and development.
Pharmaceuticals
Takeda Pharmaceutical to invest $30bn in US over 5 years: CEO
Trump's potential pharma tariffs prompt drugmakers to devise spending plans
Takeda Pharmaceutical CEO Christophe Weber said the company will invest $30 billion in the U.S. (Source photos by Nikkei)
Read Next
.JPG?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
Latest on Pharmaceuticals
